Effect of Repetitive Transcranial Direct Current Stimulation (tDCS) on Chronic Pelvic Pain
CompletedNot applicableNCT00554320
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
We will rigorously test whether modulation of the motor cortex by transcranial direct current stimulation (tDCS) is an effective treatment for patients with chronic pelvic pain through the following specific aims: A) The primary aim of this study is to determine whether transcranial direct current stimulation applied to the motor cortex in patients with chronic pelvic pain induces a significant decrease in the pain or symptoms as compared with sham tDCS. We will also measure changes in the clinical symptom scores of multiple pelvic organs, drug intake (narcotic), anxiety, depression, traumatic stress, as well as overall improvement in the quality of life to assess the effects of this treatment. B) Determine the duration of the clinical effects of tDCS. We will therefore compare the amelioration of pain and related symptoms between active and sham tDCS for one year following treatment. C) Determine whether tDCS changes the threshold for pain detection as compared with sham tDCS. Patients with chronic pelvic pain have a lower threshold for pain as compared to healthy subjects and we hypothesized that this threshold will increase after stimulation with tDCS. D) Finally, we will examine whether 5 days of tDCS treatment is safe for use in chronic pelvic pain patients. Safety will be assessed through neuropsychological tests and adverse event reporting.
Study details
- Official title
- Effect of Repetitive Transcranial Direct Current Stimulation (tDCS) on Chronic Pelvic Pain
- Conditions
- Chronic Pelvic Pain
- Interstitial Cystitis
- Post Traumatic Stress Disorder
- Fibromyalgia
- Irritable Bowel Syndrome
- Interventions
- Procedure: tDCS
- Procedure: tDCS
- Sponsor
- Summa Health System
- Start date
- 2009-01
- Primary completion
- 2009-06
- Sex
- Female
- Age range
- from 18 Years to 55 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Subjects must be females between 18 and 55 years of age. * Subjects must have a current VAS for pelvic pain of 5 or more. Exclusion Criteria: * Known pelvic malignancy. * Patients with major depression with suicidal risk as clinically defined. * Patients with other known, uncontrolled neuropsychiatric disorders. * Abnormal neurological examination other than as signs of the condition studied in the present protocol. * Contraindication to tDCS: * A history of unmanaged substance abuse or dependence within the last 6 months. * A history of previous treatment with tDCS.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00554320